Danielle Bargo is a Health Economist and Health Services Researcher with over a decade of experience generating evidence to inform health policy and support evidence-based decision-making across government, academia, and the pharmaceutical industry. She is currently a Director in U.S. Market Access at AstraZeneca and is pursuing a Doctor of Public Health degree in Health Policy and Management at the Johns Hopkins Bloomberg School of Public Health. Her research focuses on evaluating public health programs and policies, with a particular emphasis on the impact of regulations governing nonprofit hospitals and the provision of community benefits. Danielle holds a BA in Political Science from Butler University and an MSc in Social Policy with a concentration in Health Economics from the London School of Economics. Her work bridges policy analysis, research translation, and advocacy to advance affordable and accessible healthcare.